Skip to content
ALMSAlumis Inc.

Earnings

When Alumis Inc. reports, what it reported each quarter, and how the stock took the results.

15 quarters. Mar 31, 2023 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Mar 18, after the close

Thu, Mar 18, 2027in 120 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 12 – 26

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$1.93M
Revenue, change from a year earlier: Q3 2026 −7.7%, Q2 2026 −37.7%, Q1 2026 −90.0%, Q4 2025 n/m
Net income
-$92.93M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026$1.91M−7.7% vs Q3 2025

Latest results

  1. Q3 2026Nov 12, 2026, after the closeThe release
    Revenue
    $1.91M
    −7.7%
    Net income
    -$94.88M
    N/M
    EPS
    -$0.73
    N/M
    Phase 2b LUMUS trial of envudeucitinib for the treatment of moderate-to-severe systemic lupus erythematosus (SLE) did not meet its primary and secondary endpoints in the overall trial popul ation ( LINK TO PR ) .
  2. Q2 2026Aug 13, 2026, after the closeThe release+4.0%by the close of Aug 14
    Revenue
    $1.66M
    −37.7%
    Net income
    -$142.22M
    N/M
    EPS
    -$1.11
    N/M
  3. Q1 2026May 14, 2026, after the closeThe release7.4%by the close of May 15
    Revenue
    $1.74M
    −90.0%
    Net income
    -$93.05M
    N/M
    EPS
    -$0.74
    N/M
  4. Q4 2025Mar 19, 2026, after the closeThe release0.9%by the close of Mar 20
    Revenue
    $1.93M
    —
    Net income
    -$92.93M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 12, 2026 · after-hoursNov 12, 202643 d10-Q$1.91M−7.7%-$0.73—
Q2 2026Jun 30, 2026Aug 13, 2026 · after-hoursAug 13, 202644 d10-Q$1.66M−37.7%-$1.11+4.0%
Q1 2026Mar 31, 2026May 14, 2026 · after-hoursMay 14, 202644 d10-Q$1.74M−90.0%-$0.747.4%
FY 2025
Q4 2025derivedDec 31, 2025Mar 19, 2026 · after-hoursMar 19, 202678 d10-K$1.93M——0.9%
Q3 2025Sep 30, 2025Nov 13, 2025 · after-hoursNov 13, 202544 d10-Q$2.07M—-$1.06+4.4%
Q2 2025Jun 30, 2025Aug 13, 2025 · after-hoursAug 13, 202544 d10-Q$2.67M—$0.770.5%
Q1 2025Mar 31, 2025May 14, 2025 · after-hoursMay 14, 202544 d10-Q$17.39M—-$1.82+18.6%
FY 2024
Q4 2024derivedDec 31, 2024Feb 6, 2025 · after-hoursMar 19, 202578 d10-K———14.0%
Q3 2024Sep 30, 2024Nov 13, 2024 · after-hoursNov 13, 202444 d10-Q——-$1.7313.2%
Q2 2024Jun 30, 2024Aug 13, 2024 · after-hoursAug 13, 202444 d10-Q——-$23.10+2.6%
Q1 2024Mar 31, 2024——————-$21.03—
Earlier years, FY 2023 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 12, 2026000024
10-QAug 13, 2026000018
10-QMay 14, 2026000010
10-KMar 19, 2026000006
10-QNov 13, 2025000050
10-QAug 13, 2025000041
10-QMay 14, 2025000028
10-KMar 19, 2025000012
10-QNov 13, 2024000005
10-QAug 13, 2024012081

Provenance

ProvenanceData status and checks

Alumis Inc. · CIK 1847367 · Engraved from SEC EDGAR